Archive for December, 2012

Metal-on-metal hips could cause cysts on the hip flexor muscles

A new study shows that metal-on-metal hip implants such as the DePuy ASR hip replacement could cause painful cysts on the hip flexor muscles, called bursal cysts. The study, published in the December 2012 issue of Orthopedics, detailed the condition and found that the cysts could lead to severe vascular compressive symptoms.

Read more about complications caused by DePuy ASR hip replacements…

Transvaginal Mesh Lawsuits Website Launched by Hissey Kientz Law Firm

The law firm of Hissey Kientz, LLP is announcing the launch of its new transvaginal mesh lawsuit website, www.tvmlawsuithelp.com. The site will serve as a source for legal news and medical information for patients who have experienced complications after receiving transvaginal mesh implants to repair pelvic organ prolapse (POP) or stress urinary incontinence (SUI).

Read more about serious side effects caused by transvaginal mesh implants…

Wrongful death GranuFlo lawsuits to be consolidated

Wrongful death GranuFlo lawsuits against manufacturer Fresenius Medical Care (FMC) have been consolidated in a U.S. court. The patients in the lawsuits allege that FMC failed to properly warn doctors and patients about the increased deaths associated with the dialysis acid concentrates GranuFlo and NaturaLyte.

Read more about GranuFlo and NaturaLyte lawsuits…

 

Amgen agrees to pay millions for marketing Aranesp for off-label use

The biotechnology giant Amgen marketed its anemia drug Aranesp for unapproved uses even after the Food and Drug Administration explicitly ruled them out, federal prosecutors said on Tuesday. The federal charges were made public as Amgen pleaded guilty to illegally marketing the drug and agreed to pay $762 million in criminal penalties and settlements of whistle-blower lawsuits.

Read more about the Aranesp marketing lawsuits…

FDA warns against combining sodium oxybate with alcohol, CNS depressants

The Food and Drug Administration (FDA) is warning healthcare professionals that patients taking the muscle weakness and narcolepsy drug sodium oxybate (Xyrem) should not consume alcohol or use central nervous system depressants.

Read more about the Xyrem warning…

Serotonin syndrome related to antidepressants goes underreported

A new report suggests serotonin syndrome, a potentially fatal condition in which the body produces too much serotonin, goes largely underreported. The leading cause of severe cases of serotonin syndrome is selective serotonin reuptake inhibitor antidepressants (SSRIs) such as Zoloft, Paxil, Celexa and Lexapro.

Read more about serotonin syndrome caused by SSRI antidepressants…

Pfizer to pay $55M to settle Wyeth illegal Protonix marketing case

Pfizer Inc. will pay $55 million plus interest to resolve allegations that Wyeth, a company acquired by the drug maker in 2009, illegally marketed a misbranded drug for off-label use, federal prosecutors in Boston said today. Wyeth manufactured and promoted Protonix, a proton pump inhibitor used by physicians to treat various forms of gastro-esophageal reflux disease, prosecutors said.

Read more about the Wyeth illegal Protonix marketing case…


Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 435 other followers

Contact Us:

Hissey Kientz, LLP

9442 Capital of Texas Hwy N.

Arboretum Plaza One, Suite 400

Austin, Texas 78759

Toll-free: (866) 275-4454

Facsimile: (512) 320-9101

Email: info@hkllp.com

Sponsored By:

Hissey Kientz, LLP (Austin, TX)

Attorney Michael Hissey is responsible for the content of this website.